Navigation Links
Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
Date:9/22/2007

ngoing study, the company anticipates filing an NDA for TREANDA in patients with indolent NHL who are refractory to rituximab in the fourth quarter of 2007. In addition, Cephalon is studying TREANDA in combination with rituximab in patients with relapsed indolent and mantle cell NHL. The company anticipates that results from studies of TREANDA as monotherapy and in combination will be presented at medical meetings later this year.

Upon FDA acceptance of the company's NDA filing of TREANDA for CLL, the company will make a $15 million milestone payment to former shareholders of Salmedix.

About TREANDA

TREANDA is a rationally designed purine analog/alkylator hybrid. Preclinical data demonstrate that TREANDA induces rapid, sustained single- and double-strand DNA damage, which results in apoptosis, or programmed cell death, in the tumor. TREANDA also induces mitotic checkpoint inhibition, which results in non-apoptotic cell death. TREANDA causes DNA disruption that is both extensive and durable exhibiting a low level of cross-resistance to other cytotoxic agents. The dual-effect of the anti-tumor activity of TREANDA may be attributable to its unique chemical design.

Cephalon holds exclusive rights to market and develop TREANDA in the United States. TREANDA is licensed from Astellas Deutschland GmbH. Bendamustine HCl, the active ingredient in TREANDA, is marketed in Germany by Astellas' licensee, Mundipharma International Corporation Limited, under the tradename RIBOMUSTIN(R). In Germany, RIBOMUSTIN is indicated as a single-agent or in combination with other anti-cancer agents for indolent NHL, multiple myeloma, and CLL. SymBio Pharmaceuticals Ltd holds exclusive rights to market and sell bendamustine HCl in Asia.

About Cephalon Oncology

Cephalon Oncology is a strategic business unit focused on the development and commercialization of oncology products and resources for patients and healthcare providers. The Cephalon Oncology portfolio
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Provigil Patent Extension Accorded To Cephalon
2. Novartis files application with FDA for Zometa
3. Morepan to file new drug applications with the USFDA
4. Mini motor for micromedical applications
5. Perfusion bioreactor could enhance stem cell research and application in the future
6. Prostate Cancer Can Be Treated By Application Of LASER Technology
7. Varied Applications of Adult Stem Cells to Treat Host of Disorders in Human
8. Venus Remedies Files 5th International Patent Application
9. NICE supports application of advanced biological therapies as treatment option for acute psoriasis
10. Roche puts in an Application to Use Herceptin for Treatment in Her-2 positive breast cancer
11. New Drug Application Submitted for Investigational Antibiotic Doripenem
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... 2015 , ... Orthopedic surgeons at Lourdes Medical Center of Burlington County are ... a new implant to treat a common source of shoulder pain and disability. ... tendon tissue, which could allow for faster healing and a decreased chance of future ...
(Date:7/29/2015)... ... July 29, 2015 , ... Today marks a significant achievement in bringing ... growth companies and is led by a group of experienced investors, has tapped into ... with their dollars to be a part of the fund. The Sofia Fund ...
(Date:7/29/2015)... ... ... We are privileged to announce that U.S. News & World Report has ranked ... in the nation for 2015-2016. This marks the 21st consecutive year that the USC Eye ... an honor to be included in the top 10 ophthalmology hospitals by U.S. News & ...
(Date:7/29/2015)... Buckner, KY (PRWEB) , ... July 29, 2015 ... ... upcoming episode of American Farmer, airing fall of 2015 on RFD-TV. , Fastline ... segment, viewers will learn about Fastline.com, which contains the largest and freshest searchable ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired by a successful ... Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative medicine expert in ... financial need. , “We are thrilled for this opportunity to offer prolotherapy treatments ...
Breaking Medicine News(10 mins):Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:Sofia Fund Surpasses Investor Goals 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2
... role in immune response, study finds, , THURSDAY, July 30 ... with the appendix, the spleen isn,t exactly known as a ... it. , But new research suggests the spleen plays a ... In mice, scientists found, the spleen serves as a home ...
... , - New NMA President to Address ... LAS VEGAS, July 30 Delivering her inaugural address ... V. Edwards, MD, MBA, shared her plans to focus on health ... the nation,s premier organization for African American physicians. , , ...
... , SANTA CLARA, Calif., July 30 ... and green products for the home and body, today announced the ... of the proceeds from the sale of the box to cancer ... is a truly helpful gift when a friend or loved one ...
... has received over $603,000 from the Canadian Institutes of Health ... bacterial toxins leads to the development of toxic shock syndrome ... professor in the Department of Microbiology and Immunology at the ... the Lawson Health Research Institute. His research is one ...
... -- July 30, 2009 Pregnant women have a higher ... summer months due to dehydration, according to a study conducted ... The retrospective population-based study was published in the July issue ... main objective of the study was to determine whether the ...
... , , CHICAGO, July ... Augie,s Quest, the fast-track research arm of the Muscular Dystrophy Association (MDA). ... to beating the previous goal by reaching $300,000 in donations this year. ... now through August 31 and receive a free guest pass to Bally ...
Cached Medicine News:Health News:Spleen May Help Heart Recover From Disease 2Health News:National Medical Association Installs 110th President at Las Vegas Convention 2Health News:Living Green Marketplace Announces the Cancer Care Wellness Box to Bring Comfort to Cancer Patients During Medical Treatment 2Health News:Summer heat increases risk of amniotic fluid level deficiency, Ben-Gurion University study reveals 2Health News:Bally Total Fitness Flexes Fundraising Muscle to Fight ALS 2
(Date:7/29/2015)... Heska Corporation (NASDAQ: HSKA - News; "Heska" ... and other specialty veterinary products , today reported financial results ... Second Quarter 2015 Highlights with Prior Year Comparison: ... million, from $917 thousand. , Blood Analyzer and Consumables ... , Core Companion Animal revenue was up 19% to $20.7 ...
(Date:7/29/2015)... N.J. , July 29, 2015  Ortho-Clinical Diagnostics, ... five assays under development. The assays address a range ... kidney injury and cardiac troponin I. The scientific posters ... Clinical Chemistry Annual Meeting to be held July 26 ...   "Ortho Clinical Diagnostics is emerging stronger ...
(Date:7/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/sxwk89/3d_metrology ) has ... by Product (CMM, ODS, and VMM), Application (Automotive, Aerospace, ... America, Europe, APAC, RoW) - Global Forecast to 2020 ... The 3D metrology market was valued at $1,456.7 Million ... rate of 7.11% during the forecast period. ...
Breaking Medicine Technology:Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3Global 3D Metrology Market 2015-2020: Products (CMM, ODS, and VMM) & Applications (Automotive, Aerospace, Energy & Power, Medical and Electronics) 2
... Calif., Dec. 17 PEAK Surgical, Inc., a ... dissection system based on a,proprietary technology, announced today ... granted the company 510(k) clearance to market its,PEAK(R) ... tissue during,plastic and reconstructive, ENT (ear, nose and ...
... Calif., Dec. 17 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: ... independent,Data Safety Monitoring Board (DSMB) has determined that ... of acute ischemic stroke are unlikely,to show benefit. ... enrollment in,the trials. NTI will obtain and analyze ...
Cached Medicine Technology:PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: